Proteomics: Technologies and Global Markets

Jun 2009| BIO034B| BCC Publishing

Report Highlights

  • The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%.
  • Proteomics equipment was valued at $4.1 billion in 2008 and an estimated $4.8 billion in 2009. This is expected to increase to $13.0 billion in 2014, for a CAGR of 22%..
  • Proteomics technologies were worth $1.3 billion in 2008 and an estimated $1.5 billion in 2009. This segment is expected to increase at a CAGR of 13.9% to reach $2.9 billion in 2014.



  • To define global proteomics market and other aligned markets, technologies, and terms.
  • To measure the global proteomics market with respect to technologies, equipment, services, database, and software and applications.
  • To analyze intensively the market structure with respect to drivers, inhibitors, and challenges influencing the market growth.
  • To identify the trends, gaps, and opportunities in each of the micro-markets.
  • To analyze and forecast the revenues of market segments with respect to geographies (North America, Europe, Asia, and the rest of the world or ROW).
  • To strategically profile and analyze the market players and their core competencies in the field of proteomics for each of its market segment.
  • In-depth analysis of competitive scenario, top-selling products, and services of the proteomics market.
  • To track and analyze recent developments, alliances, joint ventures, mergers, and acquisitions of the market players in the industry. 
The transformation of the biopharmaceutical industry’s focus from genomics to system biology has enormously increased the importance of proteomics. The need to develop more reliable and cost-effective drugs and increasing emphasis on personalized medicines are necessitating in-depth research on proteomics. The growing awareness of protein study and research has opened up the market for various proteomic-related technologies, equipment, and services.
However, the lack of comprehensive research pertaining to this segment has always been a restraint for stakeholders. Existing reports do not provide detailed information pertaining to equipment market, complete services, a proteomic database, and software markets. This report covers the above information extensively, and includes segmentation by applications. This report not only focuses on the subsegments discussed, it also provides a complete picture of the micro-market under every subsegment portraying a complete and realistic scenario of the proteomic industry.
The report discusses segmentation of the global proteomics market as follows:
  • Technologies (based on kinds of proteomics, process and component and applications)
  • Database and software market (proteomics database, software, laboratory software programs)
  • Equipment market (2-D electrophoresis or 2-DE, chromatography systems, mass spectrometry, microfluidic (MF) chip technology and systems, microsphere analysis components, proteomics systems, protein microarrays, and others).
  • Applications market (scientific and clinical applications, and others, including homeland security and personalized medicines)
  • Services market (laboratory services, database analysis and maintenance, and others)
Each of the sections will provide market data, market drivers, trends and opportunities, top-selling products, key players, and a competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the subsegments and micro-markets. In addition, the report also provides 50 company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, and so on.
The intended audience includes the following: 
  • Proteomics technology providers
  • Proteomics equipment manufacturers and dealers
  • Proteomics laboratory service providers
  • Proteomics database and software providers
  • Biopharmaceutical (drug design and discovery) companies
  • Proteomics research companies and institutes
  • Proteomics associations  
All the market data will consist of aggregate sales figures of all submarkets within proteomics. The report focuses on the market aspects of the proteomics industry rather than on the technical aspects. We analyzed most of the new technology and product launches in the proteomics market and studied more than 500 news items. Key market developments will be sourced from the top 50 companies profiled. We researched all the technology patents over the last 5 years and documented proteomics claims to get an in-depth understanding of the utility of equipment and technology. Primary and secondary research progressed through both paid and unpaid sources to provide a greater understanding of the proteomics industry.
Sathya Durga has more than 4 years of domain experience. Apart from research and consulting, she has conducted analyst briefings for the top players in a wide range of market segments. She has often been quoted in popular websites such as,, 2012, and others. After earning her MBA (marketing and finance stream) from Chennai University, she worked with Frost & Sullivan and BOC.
Sathya Durga has authored several market research studies in the healthcare domain. Some of these include those listed below:
  • Global weight management market
  • Tele-medicines – a mainstream technology
  • High-growth markets in healthcare and life sciences
  • Carbonated soft drinks market
  • Adoption rates and analysis of OTC diabetic medicines and supplements
  • Radio Frequency Identification (RFID), Real Time Locating Systems (RTLS), IP surveillance, and other emerging technologies in the healthcare domain.
BCC offers an online information retrieval service. BCC’s home page, located at, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Frequently Asked Questions (FAQs)

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesMember Price
Full Report: Proteomics: Technologies and Global Markets232Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY2Free
Chapter- 3: MARKET OVERVIEW22Free
Chapter- 10: C. CRAMER & CO. GMBH58Free
Chapter- 11: APPENDIX15Free
Published - Jan-2002| Analyst - Valarie Natale| Code - BIO034A

Report Highlights

  • Proteomics is an emerging field that has developed in the wake of genomics. Its goal is to understand protein expression at the cellular level, and apply this information to scientific and medical problems. For example, compared to healthy cells, how does influenza virus infection affect the total protein output? Are any of the proteins expressed only in the infected cells suitable targets for new antiviral drugs? This approach also applies to cancerous cells, and cells from patients with degenerative diseases and many other conditions. New technologies like protein chips and capillary electrophoresis are emerging to serve proteomic studies, and more mature technologies like 2-D electrophoresis, mass spectroscopy, and nuclear magnetic resonance spectroscopy are being adapted for protein studies, and in some cases, for high throughput uses. Bioinformatics applications are constantly being developed to analyze the data produced by all of these technologies.
  • This BCC study examines how proteomics technologies have affected basic research and pharmaceutical research, and how they are likely to affect research in the near future. It also analyzes how proteomics technologies are developing, and examines new companies that are likely to make substantial contributions to the field. An important part of the report analyzes instruments that are vital to proteomics studies. Sales and spending projections through 2006 are included.

Market Research Report

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries